• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

帕金森病患者是否就诊过晚而无法接受器械辅助治疗,如何鼓励更了解情况和更早转诊?

Are Parkinson's disease patients referred too late for device-aided therapies and how can better informed and earlier referrals be encouraged?

机构信息

Department of Neurology, University Hospital Center Zagreb, Zagreb, Croatia.

Department of Neurology, University of Pecs, Pecs, Hungary.

出版信息

J Neural Transm (Vienna). 2023 Nov;130(11):1405-1409. doi: 10.1007/s00702-023-02680-z. Epub 2023 Aug 1.

DOI:10.1007/s00702-023-02680-z
PMID:37526767
Abstract

In the advanced Parkinson's disease, motor and non-motor symptoms become more severe and more difficult to treat. Oral therapy may become insufficient in controlling a patient´s motor complications, which results in a substantial deterioration of the patient's quality of life, ability to work and self-reliance. This is when device-aided treatments should be considered and offered, if suitable for a given patient. They include subcutaneous and intestinal infusion therapies, deep brain stimulation and, more recently, MRI-guided focussed ultrasound. Device-aided treatments should be offered in accordance with guidelines and treatment standardization. Also there is a need to ensure availability of treatment and education of patients and physicians.

摘要

在晚期帕金森病中,运动和非运动症状变得更加严重且更难以治疗。口服治疗可能不足以控制患者的运动并发症,这会导致患者的生活质量、工作能力和自理能力大幅下降。此时应考虑并提供器械辅助治疗,如果适合特定患者的话。这些治疗包括皮下和肠道输注疗法、深部脑刺激,以及最近出现的 MRI 引导聚焦超声。器械辅助治疗应根据指南和治疗标准化来提供。此外,还需要确保治疗的可及性和对患者及医生的教育。

相似文献

1
Are Parkinson's disease patients referred too late for device-aided therapies and how can better informed and earlier referrals be encouraged?帕金森病患者是否就诊过晚而无法接受器械辅助治疗,如何鼓励更了解情况和更早转诊?
J Neural Transm (Vienna). 2023 Nov;130(11):1405-1409. doi: 10.1007/s00702-023-02680-z. Epub 2023 Aug 1.
2
[Selection of the optimal device-aided therapy in Parkinson's disease].[帕金森病最佳器械辅助治疗的选择]
Ideggyogy Sz. 2019 Jan 30;72(1-2):5-11. doi: 10.18071/isz.72.0005.
3
When the going gets tough: how to select patients with Parkinson's disease for advanced therapies.当形势变得艰难时:如何选择帕金森病患者进行先进疗法。
Pract Neurol. 2013 Jun;13(3):140-52. doi: 10.1136/practneurol-2012-000463. Epub 2013 Mar 13.
4
[Characteristics of levodopa treatment in advanced Parkinson's disease in the experiences of the neurology clinics of Târgu Mureș, Romania].[罗马尼亚特尔古穆列什神经病学诊所经验中晚期帕金森病左旋多巴治疗的特点]
Orv Hetil. 2019 Apr;160(17):662-669. doi: 10.1556/650.2019.31354.
5
[Device-aided therapies in advanced Parkinson's disease].[晚期帕金森病的器械辅助治疗]
Zh Nevrol Psikhiatr Im S S Korsakova. 2016;116(12):54-60. doi: 10.17116/jnevro201611612154-60.
6
Developing consensus among movement disorder specialists on clinical indicators for identification and management of advanced Parkinson's disease: a multi-country Delphi-panel approach.在运动障碍专家中就识别和管理晚期帕金森病的临床指标达成共识:一项多国德尔菲小组方法。
Curr Med Res Opin. 2018 Dec;34(12):2063-2073. doi: 10.1080/03007995.2018.1502165. Epub 2018 Aug 20.
7
Dynamics of device-based treatments for Parkinson's disease in Germany from 2010 to 2017: application of continuous subcutaneous apomorphine, levodopa-carbidopa intestinal gel, and deep brain stimulation.2010 年至 2017 年德国基于器械的帕金森病治疗动态:持续皮下注射阿朴吗啡、左旋多巴-卡比多巴肠凝胶和深部脑刺激的应用。
J Neural Transm (Vienna). 2019 Jul;126(7):879-888. doi: 10.1007/s00702-019-02034-8. Epub 2019 Jun 20.
8
Adjunctive Therapies in Parkinson's Disease: How to Choose the Best Treatment Strategy Approach.帕金森病的辅助治疗:如何选择最佳治疗策略方法。
Drugs Aging. 2018 Dec;35(12):1041-1054. doi: 10.1007/s40266-018-0599-2.
9
Workforce participation and activities in Parkinson's disease patients receiving device-aided therapy.帕金森病患者接受设备辅助治疗后的劳动力参与和活动情况。
Acta Neurol Scand. 2018 Jul;138(1):78-84. doi: 10.1111/ane.12929. Epub 2018 Mar 22.
10
Use of advanced therapies for Parkinson's disease in Norway.挪威帕金森病先进疗法的应用。
Tidsskr Nor Laegeforen. 2017 May 2;137(9):619-623. doi: 10.4045/tidsskr.16.0711. eCollection 2017 May.

引用本文的文献

1
Parkinson's disease quality of life at 12 months comparing invasive device-aided therapy with oral treatment.比较侵入性设备辅助治疗与口服治疗12个月时帕金森病患者的生活质量。
NPJ Parkinsons Dis. 2025 Aug 11;11(1):235. doi: 10.1038/s41531-025-01093-x.
2
Grasping the big picture: impact analysis of screening tools for timely referral for device-aided therapies.把握大局:及时转介至器械辅助治疗的筛查工具的影响分析。
J Neural Transm (Vienna). 2024 Nov;131(11):1295-1305. doi: 10.1007/s00702-024-02783-1. Epub 2024 Jul 15.

本文引用的文献

1
Swedish guidelines for device-aided therapies in Parkinson's disease -Economic evaluation and implementation.瑞典帕金森病辅助治疗设备指南——经济评估与实施。
Acta Neurol Scand. 2021 Aug;144(2):170-178. doi: 10.1111/ane.13434. Epub 2021 Apr 26.
2
Parkinson's disease advanced therapies - A systematic review: More unanswered questions than guidance.帕金森病先进疗法——系统综述:未解答的问题多于指导意见。
Parkinsonism Relat Disord. 2021 Feb;83:132-139. doi: 10.1016/j.parkreldis.2020.10.042. Epub 2020 Nov 2.
3
Deep brain stimulation in early-stage Parkinson disease: Five-year outcomes.
早期帕金森病的深部脑刺激:5 年结果。
Neurology. 2020 Jul 28;95(4):e393-e401. doi: 10.1212/WNL.0000000000009946. Epub 2020 Jun 29.
4
Profile Of Patients With Advanced Parkinson's disease Suitable For Device-Aided Therapies: Restrospective Data Of A Large Cohort Of Romanian Patients.适合器械辅助治疗的晚期帕金森病患者概况:罗马尼亚一大群患者的回顾性数据
Neuropsychiatr Dis Treat. 2019 Nov 13;15:3187-3195. doi: 10.2147/NDT.S230052. eCollection 2019.
5
Characterizing advanced Parkinson's disease: OBSERVE-PD observational study results of 2615 patients.晚期帕金森病的特征:2615例患者的OBSERVE-PD观察性研究结果
BMC Neurol. 2019 Apr 2;19(1):50. doi: 10.1186/s12883-019-1276-8.
6
Adjunctive Therapies in Parkinson's Disease: How to Choose the Best Treatment Strategy Approach.帕金森病的辅助治疗:如何选择最佳治疗策略方法。
Drugs Aging. 2018 Dec;35(12):1041-1054. doi: 10.1007/s40266-018-0599-2.
7
Apomorphine and levodopa infusion for motor fluctuations and dyskinesia in advanced Parkinson disease.阿朴吗啡和左旋多巴输注治疗晚期帕金森病的运动波动和运动障碍。
J Neural Transm (Vienna). 2018 Aug;125(8):1131-1135. doi: 10.1007/s00702-018-1906-0. Epub 2018 Jul 13.
8
Patient Preferences for Device-Aided Treatments Indicated for Advanced Parkinson Disease.晚期帕金森病适用的器械辅助治疗的患者偏好
Value Health. 2017 Dec;20(10):1383-1393. doi: 10.1016/j.jval.2017.06.001. Epub 2017 Jul 20.
9
How Wearable Sensors Can Support Parkinson's Disease Diagnosis and Treatment: A Systematic Review.可穿戴传感器如何支持帕金森病的诊断与治疗:一项系统综述
Front Neurosci. 2017 Oct 6;11:555. doi: 10.3389/fnins.2017.00555. eCollection 2017.
10
Collective physician perspectives on non-oral medication approaches for the management of clinically relevant unresolved issues in Parkinson's disease: Consensus from an international survey and discussion program.帕金森病临床相关未解决问题管理中非口服药物治疗方法的集体医生观点:一项国际调查和讨论项目的共识
Parkinsonism Relat Disord. 2015 Oct;21(10):1133-44. doi: 10.1016/j.parkreldis.2015.07.020. Epub 2015 Jul 23.